Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NTLA | AMGN | VRTX | REGN | GSK |
| Company | Intellia Thera CS | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 26.21 | 314.41 | 444.72 | 980.42 | 45.06 |
| High | 26.41 | 315.81 | 447.58 | 985.00 | 45.15 |
| Low | 25.92 | 312.92 | 442.99 | 978.21 | 44.95 |
| Last | 26.21 | 314.17 | 447.05 | 980.98 | 45.12 |
| Change | -0.01 | +1.70 | +1.84 | -1.31 | +0.14 |
| % Change | -0.04% | +0.54% | +0.41% | -0.13% | +0.31% |
| Volume | 227,977 | 378,100 | 158,533 | 75,109 | 458,163 |
| 20-Day Average Volume | 1,270,540 | 2,819,241 | 1,059,766 | 441,645 | 3,320,833 |
| Previous Close | 26.22 | 312.47 | 445.21 | 982.29 | 44.98 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 23.60 | 295.69 | 414.74 | 943.41 | 43.48 |
| 20-Day Raw Stochastic | 85.64% | 85.37% | 97.82% | 94.69% | 83.76% |
| 20-Day Relative Strength | 56.20% | 64.53% | 72.54% | 61.23% | 66.40% |
| Weighted Alpha | -37.05 | +42.24 | +36.34 | +34.65 | +34.97 |
| Today's Opinion | 56% Sell | 72% Buy | 72% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 56% Sell | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 56% Sell | 8% Buy | 24% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.48% since 05/13/24 | +1.89% since 05/13/24 | +3.82% since 05/13/24 | +0.61% since 05/13/24 | -0.24% since 05/13/24 |
| Low | 25.60 on 05/14/24 | 307.47 on 05/14/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 44.74 on 05/17/24 |
| High | 27.17 on 05/15/24 | 321.44 on 05/15/24 | 447.58 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 1-Month | |||||
| %Chg | +20.77% since 04/19/24 | +16.86% since 04/19/24 | +13.21% since 04/19/24 | +9.60% since 04/19/24 | +13.36% since 04/19/24 |
| Low | 19.37 on 04/26/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 39.96 on 04/22/24 |
| High | 27.17 on 05/15/24 | 322.60 on 05/03/24 | 447.58 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -4.05% since 02/20/24 | +10.85% since 02/20/24 | +6.11% since 02/20/24 | +3.81% since 02/20/24 | +7.23% since 02/20/24 |
| Low | 19.37 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 34.87 on 02/29/24 | 322.60 on 05/03/24 | 447.58 on 05/20/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -13.97% since 11/20/23 | +18.44% since 11/20/23 | +25.09% since 11/20/23 | +22.61% since 11/20/23 | +28.34% since 11/20/23 |
| Low | 19.37 on 04/26/24 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.13 on 11/22/23 |
| High | 34.87 on 02/29/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,529,574 | 167,619,840 | 114,887,776 | 108,234,592 | 93,218,352 |
| Shares Outstanding, K | 96,475 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 36,280,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -481,190,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 28,940,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -107,440,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.85 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.06 on 05/09/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.89 | 29.26 | 26.08 | 11.11 |